1. FP532THE PROGNOSTIC VALUE OF NEPHRO-CARDIAC BIOMARKERS IN HEMODIALYSIS PATIENTS - THE RANDOMIZED-CONTROLLED MIRENDA TRIAL. (18th May 2018) Authors: Hauser, T; Malzahn, U; Betz, C; Grupp, C; Doeltz, T; Grebe, S; Murillo, E; Bausch, S; Störk, S; Krane, V; Hammer, F; Wanner, C Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FP532THE PROGNOSTIC VALUE OF NEPHRO-CARDIAC BIOMARKERS IN HEMODIALYSIS PATIENTS - THE RANDOMIZED-CONTROLLED MIRENDA TRIAL. (18th May 2018) Authors: Hauser, T; Malzahn, U; Betz, C; Grupp, C; Doeltz, T; Grebe, S; Murillo, E; Bausch, S; Störk, S; Krane, V; Hammer, F; Wanner, C Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FP532THE PROGNOSTIC VALUE OF NEPHRO-CARDIAC BIOMARKERS IN HEMODIALYSIS PATIENTS - THE RANDOMIZED-CONTROLLED MIRENDA TRIAL. (18th May 2018) Authors: Hauser, T; Malzahn, U; Betz, C; Grupp, C; Doeltz, T; Grebe, S; Murillo, E; Bausch, S; Störk, S; Krane, V; Hammer, F; Wanner, C Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗